首页> 美国卫生研究院文献>Advanced Science >Gut Microbial Signatures Can Discriminate Unipolar from Bipolar Depression
【2h】

Gut Microbial Signatures Can Discriminate Unipolar from Bipolar Depression

机译:肠道微生物特征可以将单相与双相抑郁区分开

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Discriminating depressive episodes of bipolar disorder (BD) from major depressive disorder (MDD) is a major clinical challenge. Recently, gut microbiome alterations are implicated in these two mood disorders; however, little is known about the shared and distinct microbial characteristics in MDD versus BD. Here, using 16S ribosomal RNA (rRNA) gene sequencing, the microbial compositions of 165 subjects with MDD are compared with 217 BD, and 217 healthy controls (HCs). It is found that the microbial compositions are different between the three groups. Compared to HCs, MDD is characterized by altered covarying operational taxonomic units (OTUs) assigned to the Bacteroidaceae family, and BD shows disturbed covarying OTUs belonging to Lachnospiraceae, Prevotellaceae, and Ruminococcaceae families. Furthermore, a signature of 26 OTUs is identified that can distinguish patients with MDD from those with BD or HCs, with area under the curve (AUC) values ranging from 0.961 to 0.986 in discovery sets, and 0.702 to 0.741 in validation sets. Moreover, 4 of 26 microbial markers correlate with disease severity in MDD or BD. Together, distinct gut microbial compositions are identified in MDD compared to BD and HCs, and a novel marker panel is provided for distinguishing MDD from BD based on gut microbiome signatures.
机译:区分双相情感障碍(BD)的抑郁发作与主要抑郁症(MDD)是一项重大的临床挑战。最近,肠道微生物组的改变与这两种情绪障碍有关。但是,关于MDD与BD的共有和独特的微生物特性知之甚少。在这里,使用16S核糖体RNA(rRNA)基因测序,将165名患有MDD的受试者的微生物组成与217 BD和217健康对照(HCs)进行了比较。发现三组之间的微生物组成不同。与HC相比,MDD的特征是分配给细菌科的共变操作分类单位(OTU),而BD显示属于Lachnospiraceae,Prevotellaceae和Ruminococcaceae科的受干扰的共变OTU。此外,鉴定出26个OTU的特征,可以将MDD患者与BD或HCs患者区分开,曲线下面积(AUC)值在发现组中为0.961至0.986,在验证组中为0.702至0.741。此外,26种微生物标记物中有4种与MDD或BD中的疾病严重程度相关。在一起,与BD和HCs相比,在MDD中鉴定出不同的肠道微生物成分,并提供了一种新型标记物组,用于基于肠道微生物组特征将MDD与BD区分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号